Krikštaponis Karolis, Šiugždaitė Jūratė, Vaickelionienė Rita, Mickevičius Vytautas, Grybaitė Birutė
Department of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.
Department of Veterinary Pathobiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania.
Molecules. 2025 Jun 18;30(12):2639. doi: 10.3390/molecules30122639.
The increasing number of antibiotic-resistant pathogens forces us to accelerate the search for new antimicrobial agents. Based on this, we chose to synthesize a library of 1-(2-hydroxy-5-methylphenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives and evaluate their antibacterial activity against various pathogens. A series of (2-hydroxy-5-methylphenyl)-5-oxopyrrolidine-3-carboxylic acid and its hydrazide derivatives were prepared and identified by the methods of IR, H, and C NMR spectroscopy and a microanalysis technique. The resulting compounds were evaluated in vitro for their efficacy against the Gram-positive (ATCC 9144), (ATCC 7644), and (ATCC 11778) bacterial strains as well as the Gram-negative (ATCC 8739) bacteria. Oxacillin, ampicillin, and cefuroxime were used as control antibiotics. Among the obtained compounds, hydrazone with a 5-nitrothien-2-yl fragment surpassed the control cefuroxime (7.8 μg/mL) against almost all strains tested. Hydrazone with a 5-nitrofuran-2-yl moiety showed a slightly lower but also potent effect on all bacterial strains. Moreover, hydrazone with a benzylidene moiety demonstrated very strong inhibition of (3.9 μg/mL) in comparison with the antibacterial drug cefuroxime (7.8 μg/mL). In addition, some of these compounds exhibited remarkable bactericidal properties. In a complete biofilm disruption study, 5-nitrothienylhydrazone showed excellent results in disrupting and biofilms. The test results show the potential of the newly obtained derivatives as a source of antibacterial agents. Therefore, further studies on the molecular optimization of these compounds are necessary for the development of new antibacterial drugs.
抗生素耐药病原体数量的不断增加迫使我们加快寻找新型抗菌剂的步伐。基于此,我们选择合成一系列1-(2-羟基-5-甲基苯基)-5-氧代吡咯烷-3-羧酸衍生物,并评估它们对各种病原体的抗菌活性。通过红外光谱、氢核磁共振光谱、碳核磁共振光谱和微量分析技术制备并鉴定了一系列(2-羟基-5-甲基苯基)-5-氧代吡咯烷-3-羧酸及其酰肼衍生物。对所得化合物进行体外评估,以检测其对革兰氏阳性菌(ATCC 9144、ATCC 7644和ATCC 11778)菌株以及革兰氏阴性菌(ATCC 8739)的抗菌效果。使用苯唑西林、氨苄西林和头孢呋辛作为对照抗生素。在所获得的化合物中,含有5-硝基噻吩-2-基片段的腙对几乎所有测试菌株的抗菌效果超过了对照头孢呋辛(7.8 μg/mL)。含有5-硝基呋喃-2-基部分的腙对所有细菌菌株的作用略低但也很强。此外,与抗菌药物头孢呋辛(7.8 μg/mL)相比,含有亚苄基部分的腙对金黄色葡萄球菌表现出非常强的抑制作用(3.9 μg/mL)。此外,其中一些化合物表现出显著的杀菌特性。在完整生物膜破坏研究中,5-硝基噻吩基腙在破坏金黄色葡萄球菌和大肠杆菌生物膜方面显示出优异的结果。测试结果表明新获得的衍生物作为抗菌剂来源的潜力。因此,为了开发新型抗菌药物,有必要对这些化合物进行进一步的分子优化研究。
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2020-10-19
Front Pharmacol. 2024-11-20
J Med Microbiol. 2024-3
Infect Genet Evol. 2024-1
Eur J Med Chem. 2023-3-5